meglumine has been researched along with Liver Neoplasms in 182 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.10) | 18.7374 |
1990's | 42 (23.08) | 18.2507 |
2000's | 41 (22.53) | 29.6817 |
2010's | 82 (45.05) | 24.3611 |
2020's | 15 (8.24) | 2.80 |
Authors | Studies |
---|---|
Cao, D; Chen, X; Huang, H; Lin, X; She, D; Xiong, M; Zheng, W | 1 |
Gao, W; Rao, SX; Song, D; Wang, M; Wang, W; Yang, C; Zeng, M; Zhu, K | 1 |
Cai, S; Lin, N; Lin, X; Lin, Z; Sun, Y; Wang, X; Zhao, X | 1 |
Braun, LMM; Bröker, MEE; de Man, RA; de Vries, M; Dwarkasing, RS; Ijzermans, JNM; Taimr, P | 1 |
Ardito, F; Catalano, M; Cerrito, L; De Gaetano, AM; Giraldi, L; Giuliante, F; Gullì, C; Iezzi, R; Infante, A; Manfredi, R; Marini, MG; Marrone, G; Pompili, M; Ponziani, FR; Rapaccini, GL; Rodríguez Carnero, P; Vecchio, FM | 1 |
Cauchy, F; De Vos, N; Rautou, PE; Ronot, M; Sartoris, R; Vilgrain, V | 1 |
Luciani, A; Reizine, E | 1 |
Braun, LMM; De Man, RA; Dwarkasing, RS; Ijzermans, JN; Thomeer, MG; van Koeverden, S; Vanhooymissen, IJSML; Willemssen, FE | 1 |
Amaddeo, G; Calderaro, J; Chalaye, J; Galletto Pregliasco, A; Itti, E; Kharrat, R; Kobeiter, H; Laurent, A; Legou, F; Luciani, A; Mulé, S; Regnault, H; Tacher, V; Tenenhaus, A | 1 |
Akyüz, C; Haliloğlu, M; Karçaaltıncaba, M; Oğuz, B; Özcan, HN; Seber, T; Yalçın, B | 1 |
Celmer, M; Mazur, R; Misiak, P; Pawluś, A; Pozowski, P; Sierpowska, M; Silicki, J; Szymańska, K; Zaleska-Dorobisz, U; Łasecki, M | 1 |
Bashir, MR; Erkanli, A; Gupta, RT; Marin, D; Nelson, RC; Shropshire, E; Wildman-Tobriner, B; Xiao, D; Zaki, IH; Zhang, S | 1 |
Choi, JY; Chung, YE; Kim, MJ; Kim, SU; Kim, YY; Lee, M; Park, MS | 1 |
Chen, J; He, B; Kuang, S; Rong, D; Tang, W; Wang, J; Xie, S; Zhang, L; Zhang, Y | 1 |
Chen, F; Chen, S; Chen, Z; Deng, Y; He, B; Kuang, S; Liu, W; Luo, Q; Rong, D; Wang, J; Xie, Q; Xie, S; Yang, H; Zhang, Y | 1 |
Bane, O; Cuevas, J; Cunha, GM; Fowler, KJ; Hectors, S; Kennedy, P; Lewis, S; Said, D; Sirlin, CB; Stocker, D; Taouli, B; Vietti-Violi, N | 1 |
Altenburg, MK; Burke, LM; Commander, CW; Isaacson, AJ | 1 |
Adam, G; Bannas, P; Henes, FO; Rausch, VH; Well, L | 1 |
Luciani, A; Pigneur, F; Roux, M | 1 |
Braun, L; De Man, RA; De Vries, M; Dwarkasing, R; Gest, B; IJzermans, JN; Klompenhouwer, AJ; Thomeer, MG; van Beek, H | 1 |
Beiderwellen, K; Deuschl, C; Forsting, M; Grüneisen, J; Herrmann, K; Heusch, P; Kirchner, J; Lauenstein, TC; Sawicki, LM; Umutlu, L | 1 |
Azoulay, D; Baranes, L; Calderaro, J; Charles-Nelson, A; Chiaradia, M; Costentin, C; Decaens, T; Kastahian, S; Laurent, A; Luciani, A; Mallat, A; Pigneur, F; Rahmouni, A; Roux, M; Tselikas, L | 1 |
Glockner, JF; Lee, CU; Mounajjed, T | 1 |
Allen, BC; Bashir, MR; Ho, LM; Jaffe, TA; Mazurowski, MA; Miller, CM | 1 |
Amaddeo, G; Baranes, L; Calderaro, J; Laurent, A; Legou, F; Luciani, A; Mulé, S; Pigneur, F; Rahmouni, A; Reizine, E; Roche, V; Zegai, B | 1 |
Braun, LMM; De Man, RA; Dwarkasing, RS; Gest, B; Hunink, M; Ijzermans, JN; Thomeer, MG; van Koeverden, S; Vanhooymissen, IJSML; Willemssen, FE | 1 |
Bartolotta, TV; Brancatelli, G; Lagalla, R; Matranga, D; Midiri, M; Taibbi, A | 1 |
Adens-Fauquembergue, M; Azahaf, M; Behal, H; Ernst, O; Gnemmi, V; Lebert, P; Luciani, A | 1 |
Fowler, KJ; Fraum, TJ; Khanna, G; Ludwig, DR; Rohe, E; Romberg, EK | 1 |
Ozkaya, G; Ozturk, K; Savci, G; Soylu, E; Yazici, Z | 1 |
Buc, E; Da Ines, D; Fontarensky, M; Montoriol, PF; Petitcolin, V; Poincloux, L | 1 |
Angileri, R; Cova, MA; De Paoli, L; Degrassi, F; Pantano, E; Pizzolato, R; Quaia, E; Ukmar, M | 1 |
Dahi, F; Jiang, Y; Oto, A; Rist, C; Schmid-Tannwald, C; Sethi, I | 1 |
Bruno, O; d'Assignies, G; Fina, P; Paradis, V; Ruszniewski, P; Sauvanet, A; Tubach, F; Vilgrain, V; Vullierme, MP | 1 |
Dunet, V; Koehli, M; Meuli, R; Montemurro, M; Prior, JO; Schmidt, S | 1 |
Catalano, C; De Filippis, G; Di Martino, M; Di Miscio, R; Geiger, D; Lombardo, CV; Saba, L | 1 |
Biermann, KK; de Man, RA; Dwarkasing, RS; El Addouli, H; Ijzermans, JN; Thomeer, MG; Willemssen, FE | 1 |
Angileri, R; Cabibbo, B; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E | 1 |
Agnello, F; Brancatelli, G; Cabibbo, G; Furlan, A; Genco, C; Giannitrapani, L; Lagalla, R; Marin, D; Midiri, M; Salvaggio, G | 1 |
Angthong, W; Gerber, DA; Hayashi, PH; Kim, BS; Peacock, J; Ranatunga, A; Semelka, RC; Srirattanapong, S; Woosley, JT | 1 |
Agarwal, S; Brunt, EM; Fowler, KJ; Menias, CO; Narra, VR; Shetty, AS | 1 |
Besa, C; Cooper, N; Donnerhack, C; Dyvorne, H; Facciuto, M; Kakite, S; Taouli, B | 1 |
Koh, DM; Riddell, AM; Thian, YL | 1 |
Choi, D; Jeong, WK; Kim, YK; Lim, HK; Song, KD | 1 |
Afonso, D; Herédia, V; Jeon, YH; Matos, AP; Palas, J; Ramalho, M; Semelka, RC; Sousa, MS | 1 |
Al-Hawary, MM; Davenport, MS; Glazer, DI; Hussain, HK; Kaza, RK; Khalatbari, S; Liu, PS; Maturen, KE; Patel, J; Somashekar, DK; Stein, EB; Viglianti, BL; Wasnik, AP | 1 |
Antweiler, K; Burak, M; Garlipp, B; Kalinski, T; Koelble, K; Mohnike, K; Pech, M; Ricke, J; Seidensticker, M; Seidensticker, R; Wust, P | 1 |
Bannas, P; Holmes, JH; Korosec, FR; Motosugi, U; Reeder, SB; Salmani Rahimi, M; Wang, K | 1 |
Colagrande, S; Grazioli, L; Laghi, A; Morana, G; Paolantonio, P; Ragozzino, A; Vanzulli, A | 1 |
Babyn, PS; Chavhan, GB; Kamath, BM; Mann, E | 1 |
Asbach, P; Dulce, M; Erb-Eigner, K; Hamm, B; Jiang, X; Taupitz, M; Willerding, G; Xu, K | 1 |
Kim, JH; Kim, KW; Kim, SY; Lee, MG; Lee, SJ; Shin, YM; You, MW | 1 |
Azoulay, D; Baranes, L; Calderaro, J; Chiaradia, M; Costentin, C; Decaens, T; Laurent, A; Luciani, A; Mallat, A; Pigneur, F; Rahmouni, A; Roux, M; Tselikas, L; Zafrani, ES | 1 |
Cho, ES; Kim, DJ; Kim, KA; Lee, EJ | 1 |
Bolondi, L; Colombo, M; Forzenigo, LV; Galassi, M; Golfieri, R; Granito, A; Iavarone, M; Piscaglia, F; Renzulli, M; Salvatore, V; Sangiovanni, A; Vavassori, S | 1 |
Caruso, S; Cortis, K; Liotta, R; Luca, A; Miraglia, R; Tuzzolino, F | 1 |
Brancatelli, G; Cabibbo, G; Dioguardi Burgio, M; Lagalla, R; Midiri, M; Picone, D | 1 |
Barth, BK; Becker, A; Donati, OF; Fischer, MA; Karlo, CA; Reiner, CS; Seifert, B; Ulbrich, EJ | 1 |
Cameron, AL; Duncan, JK; Ma, N; Maddern, G; Vreugdenburg, TD | 1 |
Bastien, C; Bresler, L; Brunaud, L; Klein, M; Laurent, V; Milin, S; Orry, X | 1 |
Azoulay, D; Baranes, L; Calderaro, J; Costentin, C; Herin, E; Laurent, A; Luciani, A; Mallat, A; Pigneur, F; Rahmouni, A; Roche, V; Roux, M; Tselikas, L; Zafrani, E | 1 |
Choi, BI; Choi, SH; Jang, JJ; Kim, SH; Lee, JM; Suh, KS; Yu, NC | 1 |
Abdullah, SS; Bancel, B; Baulieux, J; Berthezene, Y; Duboeuf, F; Ducerf, C; Mabrut, JY; Pialat, JB; Rode, A; Wiart, M | 1 |
Mohnike, K; Pech, M; Ricke, J; Ruhl, R; Seidensticker, M; Seidensticker, P; Staskiewicz, G; Steinberg, J; Wieners, G; Wust, P | 1 |
Catalano, C; De Filippis, G; Di Martino, M; Ginanni Corradini, S; Guerrisi, A; Marin, D; Masciangelo, R; Passariello, R; Rossi, M | 1 |
Jeon, TY; Kim, SH; Lee, WJ; Lim, HK | 1 |
Bielen, D; De Keyzer, F; Dymarkowski, S; Komuta, M; Nevens, F; Op de Beeck, K; Roebben, I; Roskams, T; Topal, B; Vandecaveye, V; Verslype, C | 1 |
Chin, K; Mangat, K | 1 |
Choi, BI; Han, JK; Kim, SH; Lee, DH; Lee, JY; Park, HS; Yoon, MA | 1 |
Besir, H; Dusak, A; Engin, H; Erdem, O; Hekimoglu, K; Kalaycioglu, B; Ustundag, Y | 1 |
Choi, BI; Han, JK; Kim, SH; Kim, SJ; Lee, JM; Lee, JY; Yoo, HJ | 1 |
Bale, R; Henninger, B; Schocke, M | 1 |
Blakeborough, A; Breuer, J; Filippone, A; Grazioli, L; Gschwend, S; Hammerstingl, R; Heinz-Peer, G; Huppertz, A; Kittner, T; Laghi, A; Leen, E; Lencioni, R; Lucidarme, O; Remplik, P; Robinson, PJ; Ruehm, SG; Schaefer, F; Stoupis, C; Tombach, B; Valette, PJ; Zech, CJ | 1 |
Choi, JS; Choi, JY; Chung, YE; Kim, JH; Kim, MJ; Lim, JS; Park, MS | 1 |
Calliada, F; Cantisani, V; Catalano, C; D'Ambrosio, U; Di Seri, M; Drudi, F; Erturk, M; Longo, F; Marigliano, C; Marin, D; Mortele, K; Pagliara, E; Passariello, R; Ricci, P | 1 |
Brubaker, LM; Elazzazi, M; Hayashi, P; Kierans, AS; Leonardou, P; Semelka, RC; Shaikh, F | 1 |
Gamst, A; Hanna, RF; Kased, N; Malek, P; Mwangi, I; Shiehmorteza, M; Sirlin, C; Wolfson, T | 1 |
Czarnecka, A; Lüdemann, L; Mohnike, K; Pech, M; Ricke, J; Rühl, R; Seidensticker, M; Streitparth, F; Wust, P | 1 |
Baek, SE; Choi, JY; Chung, YE; Hong, HS; Kim, KW; Kim, MJ; Lim, JS; Park, MS | 1 |
Pastor, CM | 1 |
Bondioni, MP; Faccioli, N; Grazioli, L; Guarise, A; Kirchin, MA; Morana, G; Schneider, G | 1 |
Wiwanitkit, V | 1 |
Burrow, B; Kalb, B; Kitajima, HD; Martin, DR; Ray, GL; Salman, KN; Sharma, P | 1 |
Fidler, J; Hough, D | 1 |
Haider, MA; Jacks, LM; Jang, HJ; Khalili, K; Kim, TK; Lee, KH; Menezes, RJ; Park, SH; Sherman, M; Yazdi, L | 1 |
Byun, JH; Jeong, WK; Kim, KW; Kim, PN; Lee, MG; Lee, SS; Shin, YM; Won, HJ | 1 |
Drobinska-Jurowiecka, A; Izycka-Swieszewska, E; Markiet, K; Nowicki, T; Studniarek, M; Szarmach, A; Szurowska, E; Wypych, J | 1 |
Albiin, N; Brismar, TB; Isaksson, B; Kartalis, N; Mihocsa, L | 1 |
Akisik, FM; Bertrand, K; Mhapsekar, R; Ramaswamy, R; Sandrasegaran, K; Saxena, R; Tahir, B | 1 |
Brown, JJ; Fowler, KJ; Narra, VR | 1 |
Albiin, N; Brismar, TB; Kartalis, N; Kylander, C | 1 |
Adsay, NV; Becker-Weidman, DJ; Chen, Z; Farris, AB; Hanish, SI; Kalb, B; Kitajima, HD; Knechtle, SJ; Lurie, CR; Martin, DR; Sharma, P; Spivey, JR | 1 |
Boll, DT; Davis, DE; Feuerlein, S; Gupta, RT; Husarik, DB; Marin, D; Merkle, EM | 1 |
Liang, W; Liu, Q; Liu, W; Xu, S | 1 |
Hekimoglu, K | 1 |
Daire, JL; Doblas, S; Garteiser, P; Haddad, N; Leitão, H; Paradis, V; Sinkus, R; Van Beers, BE; Vilgrain, V; Wagner, M | 1 |
Balabaud, C; Bioulac-Sage, P; Cailliez, H; Laumonier, H; Possenti, L; Trillaud, H; Zucman-Rossi, J | 1 |
Bova, V; Luca, A; Maruzzelli, L; Miraglia, R; Vizzini, GB | 1 |
Albrecht, T; Frericks, BB; Hohmann, J; Müller, A; Newerla, C; Reinicke, C; Skrok, J | 1 |
Bonomo, L; Ciresa, M; De Gaetano, AM; Gasbarrini, A; Gatto, A; Giuga, M; Giuliante, F; Miele, L; Pizzolante, F; Pompili, M; Rapaccini, GL; Riccardi, L; Siciliani, L; Vecchio, FM | 1 |
de Campos, RO; Hernandes, M; Kim, BS; Kim, HJ; Kim, MJ; Kim, SH; Semelka, RC | 1 |
Colagrande, S; Lucarini, S; Pradella, S | 1 |
Angileri, R; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E; Ukmar, M | 1 |
Angthong, W; Hayashi, PH; Kim, BS; Kim, SH; Semelka, RC; Srirattanapong, S; Woosley, JT | 1 |
Alexander Grant, L; Burke, C; Goh, V; Griffin, N | 1 |
Chiesa, A; Grazioli, L; Menni, K; Morana, G; Procacci, C; Schneider, G; Testoni, M | 1 |
Bazzocchi, M; Como, G; del Frate, C; Londero, V; Mortele, KJ; Ros, PR; Zanardi, R; Zuiani, C | 1 |
Gehl, HB; Kirchin, MA; Lodemann, KP; Maas, R; Rummeny, E; Schneider, G; Schultze Kool, L | 1 |
Kim, CS; Kim, YK; Lee, JM | 1 |
Reimer, P; Schima, W; Schneider, G | 1 |
Beck, A; Cho, C; Fischbach, F; Pech, M; Ricke, J; Spors, B; Warschewske, G; Wieners, G | 1 |
Kim, CS; Kim, YK; Kwak, HS; Lee, JM; Lee, YH | 1 |
Kim, CS; Kim, YK; Kwak, HS; Lee, JM | 1 |
Grazioli, L | 1 |
Leen, E | 1 |
Chung, GH; Kim, CS; Kim, CY; Kim, IH; Kim, YK; Lee, JM | 1 |
Arduini, F; Cantisani, V; Filpo, M; Laghi, A; Pacella, S; Pagliara, E; Paolantonio, P; Pasqualini, V; Passariello, R; Ricci, P; Trippa, F | 1 |
Al-Abadi, H; Cho, CH; Felix, R; Hengst, S; Lopez Hänninen, E; Lüdemann, L; Mohnike, K; Pech, M; Ricke, J; Seidensticker, M; Wieners, G; Wust, P | 1 |
Grazioli, L; Kirchin, MA; Morana, G; Schneider, G | 1 |
Ouyang, H; Zhang, HM; Zhou, CW | 1 |
Ward, J | 1 |
Aliberti, C; Benea, G; De Giorgi, U; Kopf, B | 1 |
Arrivé, L; Belghiti, J; Bridel, E; Fléjou, JF; Handra-Luca, A; Lewin, M; Paradis, V; Tubiana, JM; Vilgrain, V; Wendum, D | 1 |
Altmeyer, K; Grazioli, L; Kirchin, MA; Morana, G; Saini, S; Schneider, G; Seidel, R | 1 |
Han, YM; Kim, CS; Kim, YK; Lee, YH | 1 |
Mainardi, LT; Passera, KM; Potepan, P; Setti, E | 1 |
Brancatelli, G; Catalano, C; Federle, MP; Lagalla, R; Marin, D; Midiri, M; Passariello, R; Vilgrain, V | 1 |
Beaty, SD; Depetris, G; Silva, AC | 1 |
Ida, M; Inoue, K; Itoh, H; Kadoya, M; Matsui, O; Suzuki, M; Takashima, T | 1 |
Bompiani, C; Rossi, P; Rovighi, L; Simonetti, G; Tipaldi, L | 1 |
Shimatani, Y; Suto, Y | 1 |
Casillas, C; Ferrer, MD; Martí-Bonmatí, L; Masiá, L; Torrijo, C | 1 |
Bagley, AS; Brown, ED; Larson, RE; Lee, JK; Molina, PL; Semelka, RC | 1 |
Arakawa, A; Hatanaka, Y; Matsukawa, T; Miyazaki, T; Takahashi, M; Yamamoto, H; Yamashita, Y | 1 |
Arita, T; Choji, T; Fujita, T; Honjo, K; Ito, K; Matsumoto, T; Nakanishi, T | 1 |
Bartolozzi, C; Caramella, D; Ciancia, EM; Lencioni, R; Mazzeo, S | 1 |
Dabatin, JF; Francis, IR; Glazer, GM; Herfkens, RJ; Jeffrey, RB; Li, KC; Low, RN; McDonnell, CH; Van Dalsem, WJ; Whitney, WS | 1 |
Baron, RL; Confer, SR; Dodd, GD; Federle, MP; Ohtomo, K; Ohtomo, Y | 1 |
Hamm, B; Mahfouz, AE; Wolf, KJ | 1 |
Bernardino, ME; Gould, RG; Hamm, B; Lüning, M; Mahfouz, AE; Saini, S; Taupitz, M; Thoeni, RF; Wolf, KJ | 1 |
Hori, S; Kozuka, T; Mitani, T; Monden, M; Murakami, T; Nakamura, H; Nakanishi, K; Tomoda, K; Tsuda, K; Wakasa, K | 1 |
Foo, TK; Francis, IR; Glazer, GM; Herfkens, RJ; Jeffrey, RB; Low, RN; Pelc, NJ; Shimakawa, A | 1 |
Andoh, K; Itoh, Y; Kinno, Y; Odagiri, K; Tarao, K | 1 |
Hamm, B; Mahfouz, AE; Taupitz, M; Wolf, KJ | 1 |
Foo, TK; Francis, IR; Low, RN; Sigeti, JS | 1 |
Grandin, C; Levesque, M; Pringot, J; Soyer, P; Van Beers, B | 1 |
Caudana, R; Di Rito, R; Morana, G; Nicoli, N; Pirovano, GP; Pistolesi, GF; Portuese, A; Spinazzi, A | 1 |
Giovagnoni, A; Paci, E | 1 |
Pezzoli, C; Pirovano, G; Ratcliffe, G; Rosati, G; Spinazzi, A | 1 |
Hirohashi, S; Kadoya, M; Katayama, H; Kuwatsuru, R; Tanimoto, A | 1 |
Abe, Y; Mitsuzaki, K; Miyazaki, T; Namimoto, T; Ogata, I; Sumi, S; Takahashi, M; Urata, J; Yamashita, Y | 1 |
Baron, RL; Murakami, T; Peterson, MS | 1 |
DeCorato, DR; Earls, JP; Krinsky, GA; Rofsky, NM; Weinreb, JC | 1 |
Blakeborough, A; Griffiths, M; Guthrie, JA; Kajiya, Y; Robinson, PJ; Ward, J; Wilson, D | 1 |
Atilla, S; Borrello, JA; Brown, JJ; Pilgram, TK; Quillin, SP; Yu, CY | 1 |
Choi, BI; Han, JK; Han, MC; Jang, HJ; Kim, TK | 1 |
Gouhiri, M; Rondeau, Y; Rymer, R; Scherrer, A; Soyer, P; Spelle, L | 1 |
Diebold, T; Felix, R; Hammerstingl, R; Lodemann, KP; Mack, M; Neuhaus, P; Pegios, W; Stupavsky, A; Vogl, TJ | 1 |
Itai, Y | 1 |
Kirchin, M; Lorusso, V; Pirovano, G; Spinazzi, A | 1 |
Baron, RL; Cotroneo, AR; De Franco, A; De Gaetano, AM; Manfredi, R; Marano, P; Maresca, G; Pirovano, G; Spinazzi, A | 1 |
Hahn, PF; Harisinghani, M; Mayo-Smith, W; Petersein, J; Saini, S; Schima, W; Weissleder, R | 1 |
Funahashi, Y; Ogawa, T; Ono, H; Senba, T; Takamura, T; Yoshikawa, K | 1 |
Hiramatsu, K; Hirohashi, S; Kadoya, M; Katayama, H; Kuwatsuru, R; Murakami, T; Ohtomo, K; Tanimoto, A; Yoshikawa, K | 1 |
Hamm, B; Kirchin, M; Pirovano, G; Spinazzi, A | 1 |
Grazioli, L; Kirchin, M; Pirovano, G; Spinazzi, A | 1 |
Hirohashi, S; Kadoya, M; Katayama, H; Kuwatsuru, R; Murakami, T; Ohtomo, K; Tanaka, Y; Tanimoto, A; Yoshikawa, K | 2 |
Bartolozzi, C; Spinazzi, A | 1 |
Benetti, A; Caudana, R; Colombari, R; Grazioli, L; Kirchin, MA; Morana, G; Pirovano, G; Portolani, N; Spinazzi, A; Talamini, G | 1 |
Bartolozzi, C; Bloem, JL; Chiesa, A; Claussen, C; Daldrup, HE; Giovagnoni, A; Grazioli, L; Greco, A; Hamm, B; Heuck, A; Kirchin, MA; Laniado, M; Lencioni, R; Manfredi, R; Marano, P; Marchal, G; McNamara, MT; Petersein, J; Petre, C; Pirovano, G; Reiser, M; Rummeny, E; Soyer, P; Spinazzi, A; Terrier, F; Van Persijn Van Meerten, EL | 1 |
Arneson, V; Daldrup-Link, HE; Grazioli, L; Greco, A; Hamm, B; Holzknecht, N; Imperatori, L; Kirchin, MA; Manfredi, R; Marti-Bonmati, L; Pirovano, G; Rummeny, E; Spinazzi, A; Vanzulli, A | 1 |
Bourne, M; Gehl, HB; Grazioli, L; Lodemann, KP; Möller, A | 1 |
De Cobelli, F; De Gaspari, A; Del Maschio, A | 1 |
Helmberger, T; Semelka, RC | 1 |
Katayama, H; Kuwatsuru, R | 1 |
Benoit, Y; Mortelé, B; Mortelé, KJ; Ros, PR; Vanzieleghem, B | 1 |
Kirchin, MA; Spinazzi, A | 1 |
Eibl-Eibesfeldt, B; Hammerstingl, R; Lissner, J; Peqios, W; Schnell, B; Vogl, TJ | 1 |
Berthezène, Y; Brasch, RC; Clément, O; Mühler, A; Rosenau, W; Vexler, V | 1 |
Peters, PE; Rummeny, EJ | 1 |
Concepcion, R; Feuerstein, I; Marincola, F; Premkumar, A; Sanders, L; Schwartzentruber, D | 1 |
17 review(s) available for meglumine and Liver Neoplasms
Article | Year |
---|---|
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Gadolinium DTPA; Hemangioma; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2013 |
The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Radiography | 2013 |
Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prevalence; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Utilization Review | 2017 |
Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diffusion Magnetic Resonance Imaging; Focal Nodular Hyperplasia; Gadolinium DTPA; Hemangioma; Hepatocytes; Humans; Incidental Findings; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2011 |
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Topics: Bile Duct Neoplasms; Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2013 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed | 2004 |
MultiHance in liver lesion detection: personal experience.
Topics: Contrast Media; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Tomography, X-Ray Computed | 2004 |
MultiHance-enhanced MRI in the characterisation of focal liver lesions.
Topics: Contrast Media; Diagnosis, Differential; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Time Factors | 2004 |
New MR techniques for the detection of liver metastases.
Topics: Adenocarcinoma; Artifacts; Colorectal Neoplasms; Contrast Media; Cysts; Equipment Design; Fatty Liver; Forecasting; Gadolinium; Gadolinium DTPA; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2006 |
Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media.
Topics: Adult; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron Compounds; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2008 |
Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Safety | 1996 |
Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of multicenter studies in Europe and the USA.
Topics: Carcinoma, Hepatocellular; Clinical Trials as Topic; Contrast Media; Europe; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Safety; United States | 1999 |
MultiHance: help or hype?
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 1999 |
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 2001 |
New contrast agents for imaging the liver.
Topics: Animals; Contrast Media; Edetic Acid; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2001 |
[Hepatocyte targeted MR contrast agent--Gd-BOPTA(E-7155)].
Topics: Animals; Carcinoma, Hepatocellular; Clinical Trials as Topic; Contrast Media; Diagnosis, Differential; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2001 |
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
21 trial(s) available for meglumine and Liver Neoplasms
Article | Year |
---|---|
Assessment of the tolerance dose of the hepatic reticulo-endothelial system (RES) after single fraction HDR-irradiation: an in-vivo study employing SSPIO.
Topics: Aged; Brachytherapy; Contrast Media; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Edema; Endpoint Determination; Female; Ferric Compounds; Hepatocytes; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Magnetics; Male; Meglumine; Middle Aged; Mononuclear Phagocyte System; Organometallic Compounds; Phagocytosis; Radiation Dosage; Radiation Tolerance; Time Factors; Tomography, X-Ray Computed | 2008 |
Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Double-Blind Method; Europe; Gadolinium DTPA; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Is hepatotropic contrast enhanced MR a more effective method in differential diagnosis of hemangioma than multi-phase CT and unenhanced MR?
Topics: Adolescent; Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Hemangioma, Cavernous; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine.
Topics: Administration, Oral; Aged; Colorectal Neoplasms; Contrast Media; Cross-Over Studies; Female; Humans; Injections, Intravenous; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Meglumine; Middle Aged; Organometallic Compounds; Phospholipids; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Sulfur Hexafluoride; Ultrasonography | 2012 |
Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison.
Topics: Adult; Aged; Contrast Media; Cross-Over Studies; Double-Blind Method; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2003 |
Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
Topics: Carcinoma, Hepatocellular; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Humans; Image Enhancement; Imaging, Three-Dimensional; Iron; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Oxides; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity | 2004 |
[Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2006 |
Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
Topics: Adult; Aged; Contrast Media; Female; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2007 |
Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application.
Topics: Contrast Media; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 1996 |
[Early phase II trial of Gd-BOPTA (E7155) for the MR imaging of liver tumors].
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 1996 |
Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation.
Topics: Carcinoma, Hepatocellular; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Time Factors | 1997 |
Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers.
Topics: Adult; Aged; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pilot Projects; Single-Blind Method | 1999 |
Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA).
Topics: Aged; Carcinoma, Hepatocellular; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds | 1999 |
MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Sensitivity and Specificity | 1999 |
MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.
Topics: Adenoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Focal Nodular Hyperplasia; Gadolinium; Hemangioma; Humans; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies | 1999 |
Clinical late phase II trials of MultiHance (Gd-BOPTA) for the magnetic resonance imaging of liver tumors in Japan.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Humans; Japan; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Safety | 1999 |
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Europe; Female; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity | 2000 |
Off-site evaluation of liver lesion detection by Gd-BOPTA-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Echo-Planar Imaging; Female; Gadolinium; Humans; Injections, Intravenous; Liver Neoplasms; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed | 2001 |
Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2001 |
Low-dose gadobenate dimeglumine-enhanced MRI in the detection and characterization of focal liver lesions.
Topics: Carcinoma, Hepatocellular; Contrast Media; Hemangioma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Sensitivity and Specificity | 2002 |
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
144 other study(ies) available for meglumine and Liver Neoplasms
Article | Year |
---|---|
Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2022 |
A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies | 2022 |
Quantitative parameters obtained from gadobenate dimeglumine-enhanced MRI at the hepatobiliary phase can predict post-hepatectomy liver failure and overall survival in patients with hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Hepatectomy; Humans; Liver Failure; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2022 |
Performance of Contrast-Enhanced Sonography Versus MRI With a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia.
Topics: Adenoma, Liver Cell; Adolescent; Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sulfur Hexafluoride; Ultrasonography; Young Adult | 2020 |
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging.
Topics: Aged; Carcinoma, Hepatocellular; Cell Differentiation; Consensus; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Radiologists; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity | 2019 |
Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Reply to "Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia".
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Contrast Media; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2020 |
Response to Letter: Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of HCA From FNH.
Topics: Contrast Media; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2020 |
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Choline; Contrast Media; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2020 |
Hepatocyte-specific contrast-enhanced MRI findings of focal nodular hyperplasia-like nodules in the liver following chemotherapy in pediatric cancer patients.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Drug Therapy; Female; Focal Nodular Hyperplasia; Follow-Up Studies; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Infant; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies | 2020 |
Atypical Enhancement of Gd-BOPTA on the Hepatobiliary Phase in Hepatic Metastasis from Carcinoid Tumor - Case Report.
Topics: Aged; Carcinoid Tumor; Contrast Media; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2020 |
How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?
Topics: Aged; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2021 |
MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Longitudinal Studies; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Assessment | 2020 |
The role of lesion hypointensity on gadobenate dimeglumine-enhanced hepatobiliary phase MRI as an additional major imaging feature for HCC classification using LI-RADS v2018 criteria.
Topics: Carcinoma, Hepatocellular; Contrast Media; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2021 |
Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2021 |
Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
Topics: Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Perfusion; Prospective Studies | 2021 |
Do Radiopaque Polyvinyl Alcohol Beads Cause Artifact on Postcontrast MR Imaging?
Topics: Artifacts; Contrast Media; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Microspheres; Organometallic Compounds; Phantoms, Imaging; Polyvinyl Alcohol; Tomography, X-Ray Computed | 2017 |
Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Ascites; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Germany; Humans; Infusions, Intravenous; Liver; Liver Cirrhosis; Liver Neoplasms; Lung Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pleural Effusion; Risk Factors; Young Adult | 2017 |
Response to "Quantitative analysis of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of llcer method using gadobenate dimeglumine as contrast agent".
Topics: Carcinoma, Hepatocellular; Contrast Media; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Meglumine; Organometallic Compounds | 2018 |
Quantitative analysis Of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of LLCER method using gadobenate dimeglumine as contrast agent.
Topics: Carcinoma, Hepatocellular; Contrast Media; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2018 |
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
Topics: Adenoma, Liver Cell; Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2018 |
Inflammatory hepatic adenomas: Characterization with hepatobiliary MRI contrast agents.
Topics: Adenoma; Adult; Contrast Media; Diffusion Magnetic Resonance Imaging; Fatty Liver; Female; Focal Nodular Hyperplasia; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Inflammation; Liver; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Young Adult | 2018 |
Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2018 |
Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Topics: Adenoma, Liver Cell; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organic Anion Transporters; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2018 |
Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Topics: Adenoma, Liver Cell; Adult; Contrast Media; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Reference Standards; Reproducibility of Results; Retrospective Studies; Young Adult | 2019 |
Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI.
Topics: Adult; Contrast Media; Evaluation Studies as Topic; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2019 |
MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
Topics: Adenoma, Liver Cell; Adult; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Fatty Liver; Female; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2019 |
Diagnostic performance of Liver Imaging Reporting and Data System (LI-RADS) v2017 in predicting malignant liver lesions in pediatric patients: a preliminary study.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Female; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
Differentiation of hepatocellular carcinoma from non-hepatocellular malignant tumours of liver by chemical-shift MRI at 3 T.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2019 |
Advantages of gadobenate dimeglumine-enhanced MR cholangiography in the diagnosis of post-liver transplant bile leakage.
Topics: Adult; Anastomotic Leak; Bile; Bile Duct Diseases; Carcinoma, Hepatocellular; Cholangiography; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Female; Hepatitis C, Chronic; Humans; Image Enhancement; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Liver Transplantation; Male; Meglumine; Middle Aged; Organometallic Compounds; Postoperative Complications | 2013 |
Predictors of dysplastic nodule diagnosis in patients with liver cirrhosis on unenhanced and gadobenate dimeglumine-enhanced MRI with dynamic and hepatobiliary phase.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2013 |
Diffusion-weighted MR imaging of focal liver lesions in the left and right lobes: is there a difference in ADC values?
Topics: Adult; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds | 2013 |
High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
Topics: Adult; Aged; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Hepatectomy; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2013 |
Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Topics: Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Male; Meglumine; Middle Aged; Multimodal Imaging; Observer Variation; Organometallic Compounds; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Treatment Outcome | 2013 |
Detection of small (≤2 cm) HCC in cirrhotic patients: added value of diffusion MR-imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Cirrhosis; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Sensitivity and Specificity | 2013 |
MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents.
Topics: Adenoma, Liver Cell; Adult; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Hepatitis; Hepatocytes; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Image Interpretation, Computer-Assisted; Iohexol; Iopamidol; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Phospholipids; Reproducibility of Results; Retrospective Studies; Subtraction Technique; Sulfur Hexafluoride; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iopamidol; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Niacinamide; Organometallic Compounds; Phenylurea Compounds; Sorafenib; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Liver adenomatosis: serial investigation on MRI.
Topics: Adenoma; Adolescent; Adult; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Remission, Spontaneous; Retrospective Studies | 2014 |
Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Phenotype; Risk Factors; Tomography, X-Ray Computed | 2014 |
Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Neoplasms; Male; Meglumine; Middle Aged; Motion; Observer Variation; Organometallic Compounds; Prospective Studies; Reproducibility of Results | 2015 |
Perilesional enhancement of liver cavernous hemangiomas in magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Hemangioma, Cavernous; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Young Adult | 2014 |
Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Clinical Competence; Contrast Media; Female; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies | 2014 |
Radiation-induced liver damage: correlation of histopathology with hepatobiliary magnetic resonance imaging, a feasibility study.
Topics: Aged; Brachytherapy; Contrast Media; Feasibility Studies; Female; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Radiation Injuries | 2015 |
Combined dynamic contrast-enhanced liver MRI and MRA using interleaved variable density sampling.
Topics: Adult; Algorithms; Contrast Media; Data Interpretation, Statistical; Female; Hemangioma, Cavernous, Central Nervous System; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Magnetic Resonance Angiography; Male; Meglumine; Organometallic Compounds; Reproducibility of Results; Sample Size; Sensitivity and Specificity | 2015 |
MRI of hepatic epithelioid hemangioendothelioma (HEH).
Topics: Adult; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium DTPA; Hemangioendothelioma, Epithelioid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2014 |
Gadobenate-dimeglumine-enhanced magnetic resonance imaging for hepatic lesions in children.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Dynamic contrast-enhanced MRI of ocular melanoma.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Eye Neoplasms; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prognosis; Prospective Studies; Time Factors | 2015 |
Recent advances in the imaging of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Oxides; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
Topics: Adenoma, Liver Cell; Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Young Adult | 2015 |
Effect of increasing the flip angle during the hepatocyte phase of gadobenate dimeglumine-enhanced 1.5T MRI in cirrhotic patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Hepatocytes; Humans; Image Enhancement; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Radiology; Retrospective Studies; Signal-To-Noise Ratio | 2016 |
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Female; Gadolinium DTPA; Hepatocytes; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2015 |
Incorporating the hepatobiliary phase of gadobenate dimeglumine-enhanced MRI in the diagnosis of hepatocellular carcinoma: increasing the sensitivity without compromising specificity.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2016 |
MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2016 |
Reliability, Validity, and Reader Acceptance of LI-RADS-An In-depth Analysis.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Radiology Information Systems; Reproducibility of Results; Retrospective Studies; ROC Curve | 2016 |
Prevalence of hepatic lesion types defined by T2-weighted and dynamic gadolinium-enhanced MR imaging in patients with metastasized neuroendocrine tumors.
Topics: Adult; Aged; Contrast Media; Female; France; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Prevalence; Retrospective Studies | 2016 |
Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.
Topics: Adenoma; Adult; Contrast Media; Female; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity; Ultrasonography | 2017 |
Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2008 |
Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI.
Topics: Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast Media; Female; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Statistics, Nonparametric | 2008 |
Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2010 |
Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma.
Topics: Algorithms; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Cirrhosis; Liver Neoplasms; Meglumine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Radiofrequency ablation of colorectal liver metastases in a transplanted liver.
Topics: Catheter Ablation; Cholangitis, Sclerosing; Colorectal Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Humans; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Middle Aged; Organometallic Compounds; Tomography, X-Ray Computed | 2009 |
Value of dual contrast liver MRI at 3.0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: preliminary results of multivariate analysis.
Topics: Algorithms; Contrast Media; Dextrans; Drug Combinations; Female; Ferrosoferric Oxide; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetite Nanoparticles; Male; Meglumine; Multivariate Analysis; Organometallic Compounds; Pilot Projects; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Dextrans; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Enhancement; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2009 |
[Multiple cavernous hemangioma progressing in size in a cirrhotic liver].
Topics: Biopsy; Contrast Media; Diagnosis, Differential; Disease Progression; Follow-Up Studies; Hemangioma, Cavernous; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Ultrasonography | 2010 |
Detection of hepatic hypovascular metastases: 3D gradient echo MRI using a hepatobiliary contrast agent.
Topics: Aged; Algorithms; Biliary Tract; Contrast Media; Female; Humans; Image Enhancement; Liver; Liver Neoplasms; Male; Meglumine; Middle Aged; Neovascularization, Pathologic; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Phospholipids; Prospective Studies; Reference Standards; Sensitivity and Specificity; Sulfur Hexafluoride; Tomography, Spiral Computed; Ultrasonography | 2010 |
MRI findings of rapidly progressive hepatocellular carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2010 |
Apparent diffusion coefficient of fibrosis and regenerative nodules in the cirrhotic liver at MRI.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Interpretation, Computer-Assisted; Liver Cirrhosis; Liver Neoplasms; Liver Regeneration; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Regression Analysis | 2010 |
Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Brachytherapy; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Follow-Up Studies; Hepatocytes; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Radiation Tolerance; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2010 |
Characterisation of small hypoattenuating hepatic lesions in multi-detector CT (MDCT) in patients with underlying extrahepatic malignancy: added value of contrast-enhanced MR images.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Gadoxetic acid-enhanced hepatobiliary phase MR imaging: cellular insight.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats | 2010 |
Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Contrast Media; Female; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2011 |
MRI findings of hepatocellular carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2011 |
Optimization of single injection liver arterial phase gadolinium enhanced MRI using bolus track real-time imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Computer Simulation; Contrast Media; Female; Hepatic Artery; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Injections, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Models, Biological; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2011 |
Hepatocyte-specific magnetic resonance imaging contrast agents.
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Hepatocytes; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds | 2011 |
Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Population Surveillance; Practice Guidelines as Topic; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2011 |
Gadobenate dimeglumine-enhanced liver MR imaging in cirrhotic patients: quantitative and qualitative comparison of 1-hour and 3-hour delayed images.
Topics: Adult; Aged; Contrast Media; Female; Fibrosis; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; ROC Curve; Time Factors; Treatment Outcome | 2011 |
The added value of contrast-enhanced ultrasound in patients with colorectal cancer undergoing preoperative evaluation with extensive gadobenate dimeglumine liver MRI.
Topics: Colorectal Neoplasms; Contrast Media; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Medical Oncology; Meglumine; Neoplasm Metastasis; Organometallic Compounds; Predictive Value of Tests; Sensitivity and Specificity; Time Factors; Ultrasonography | 2011 |
Does the hepatocellular phase of gadobenate dimeglumine help to differentiate hepatocellular carcinoma in cirrhotic patients according to histological grade?
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; ROC Curve | 2011 |
Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2011 |
Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Topics: Contrast Media; Female; Gadolinium DTPA; Hemangioma; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Detection of hepatic metastases: gadolinium-enhanced MR imaging versus superparamagnetic iron oxide-enhanced MR imaging versus diffusion-weighted imaging.
Topics: Colorectal Neoplasms; Dextrans; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Organometallic Compounds; Tomography, X-Ray Computed | 2013 |
Re: detection of hepatic metastases: gadolinium-enhanced MR imaging versus superparamagnetic iron oxide-enhanced MR imaging versus diffusion-weighted imaging.
Topics: Colorectal Neoplasms; Dextrans; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Organometallic Compounds; Tomography, X-Ray Computed | 2013 |
Diffusion-weighted MR imaging for the regional characterization of liver tumors.
Topics: Adult; Aged; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Meglumine; Middle Aged; Necrosis; Organometallic Compounds; Prospective Studies; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric | 2012 |
Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
Topics: Adenoma, Liver Cell; Adult; beta Catenin; Biomarkers, Tumor; Contrast Media; Diagnosis, Differential; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Inflammation; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds; Phenotype; Phospholipids; Retrospective Studies; Sensitivity and Specificity; Sulfur Hexafluoride; Ultrasonography | 2012 |
Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies.
Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Contrast Media; Embolization, Therapeutic; Female; Humans; Iohexol; Liver Neoplasms; Liver Transplantation; Logistic Models; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Predictive Value of Tests; Treatment Outcome; Triiodobenzoic Acids | 2013 |
Hepatic transit time analysis using contrast enhanced MRI with Gd-BOPTA: A prospective study comparing patients with liver metastases from colorectal cancer and healthy volunteers.
Topics: Aged, 80 and over; Blood Flow Velocity; Colorectal Neoplasms; Contrast Media; Female; Hepatic Artery; Humans; Liver Circulation; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pulse Wave Analysis | 2012 |
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
Topics: Aged; Biopsy, Large-Core Needle; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2013 |
Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Topics: Adenoma, Liver Cell; Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Hemangioma; Hepatic Artery; Hepatocytes; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Mass Screening; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Retrospective Studies; Sensitivity and Specificity | 2013 |
Liver lesion characterization: the wrong choice of contrast agent can mislead the diagnosis of hemangioma.
Topics: Adult; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Hemangioma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2012 |
Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Topics: Aged; Aged, 80 and over; Arteries; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Contrast Media; Female; Focal Nodular Hyperplasia; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prospective Studies | 2013 |
Outcomes of patients with elevated α-fetoprotein level and initial negative findings at MR imaging.
Topics: Adult; Aged; alpha-Fetoproteins; Analysis of Variance; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2013 |
Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA.
Topics: Contrast Media; Diagnosis, Differential; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Sensitivity and Specificity; Statistics, Nonparametric | 2002 |
Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.
Topics: Colorectal Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Organometallic Compounds; Oxides; Suspensions | 2002 |
Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Probability; Prospective Studies; Sampling Studies; Sensitivity and Specificity | 2004 |
[Comparison of different MRI sequences with and without application of Gd-BOPTA as follow-up after LITT].
Topics: Contrast Media; Data Interpretation, Statistical; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Lasers; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Quality Assurance, Health Care | 2004 |
Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Organometallic Compounds; Oxides; Predictive Value of Tests; Radionuclide Imaging | 2004 |
Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging.
Topics: Adult; Aged; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Humans; Image Processing, Computer-Assisted; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Oxides; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity | 2005 |
Contrast-enhanced sonography with SonoVue: enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Radiography; Ultrasonography | 2005 |
In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Contrast Media; Dose-Response Relationship, Radiation; Edema; Female; Hepatocytes; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Radiation Tolerance | 2005 |
Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
Topics: Adenoma; Adult; Chi-Square Distribution; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2005 |
Hepatic metastases of hemangiopericytoma: contrast-enhanced MRI, contrast-enhanced ultrasonography and angiography findings.
Topics: Abdominal Pain; Angiography; Chemotherapy, Adjuvant; Combined Modality Therapy; Contrast Media; Hemangiopericytoma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retroperitoneal Neoplasms; Tomography, Spiral Computed; Ultrasonography | 2006 |
Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings.
Topics: Adenoma, Liver Cell; Adult; Contrast Media; Diagnosis, Differential; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2006 |
Added diagnostic value of T2-weighted MR imaging to gadolinium-enhanced three-dimensional dynamic MR imaging for the detection of small hepatocellular carcinomas.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2008 |
Improved detection of liver metastasis by registration and subtraction of dynamic contrast-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Algorithms; Contrast Media; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Signal Processing, Computer-Assisted | 2007 |
AJR teaching file: incidental hepatic mass.
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Hepatitis C, Chronic; Humans; Incidental Findings; Liver Failure; Liver Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Tomography, X-Ray Computed | 2008 |
Work in progress: dynamic sequential computed tomography during arterial portography in the detection of hepatic neoplasms.
Topics: Angiography; Carcinoma, Hepatocellular; Hepatic Artery; Humans; Liver Neoplasms; Meglumine; Portography; Tomography, X-Ray Computed | 1983 |
High contrast enhancement of the liver in CT by repeated doses of contrast medium.
Topics: Adult; Diatrizoate Meglumine; Humans; Iodamide; Iodipamide; Liver Diseases; Liver Neoplasms; Male; Meglumine; Middle Aged; Radiographic Image Enhancement; Tomography, X-Ray Computed | 1981 |
Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chondroitin Sulfates; Colloids; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1995 |
Dynamic MR imaging of liver tumors: analysis with temporal reconstruction images.
Topics: Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Hemangioma; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Time Factors | 1994 |
Hypervascular malignant liver lesions: comparison of various MR imaging pulse sequences and dynamic CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Retrospective Studies; Tomography, X-Ray Computed | 1994 |
Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging.
Topics: Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multivariate Analysis; Organometallic Compounds; Pentetic Acid; Retrospective Studies | 1994 |
Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
Topics: Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Radiography | 1994 |
Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Ethanol; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Time Factors | 1994 |
Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Heterocyclic Compounds; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity | 1993 |
Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging.
Topics: Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed | 1993 |
Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions.
Topics: Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity | 1994 |
Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Pentetic Acid; Prospective Studies; ROC Curve; Sensitivity and Specificity | 1994 |
Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.
Topics: Aged; Carcinoma, Hepatocellular; Drug Combinations; Embolization, Therapeutic; Female; Gadolinium DTPA; Humans; Iodized Oil; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Drug Combinations; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Gadopentetate dimeglumine as an alternative contrast material for use in angiography.
Topics: Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Embolization, Therapeutic; Gadolinium; Gadolinium DTPA; Hepatic Artery; Humans; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Rupture, Spontaneous | 1993 |
Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
Topics: Adult; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Humans; Hyperplasia; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Abdominal MR imaging: comparison of T2-weighted fast and conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging.
Topics: Abdomen; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Primary lymphoma of the liver: MR findings.
Topics: Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Multicenter testing of gadobenate dimeglumine in magnetic resonance imaging of focal liver disease.
Topics: Contrast Media; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Sensitivity and Specificity | 1996 |
Gadolinium-enhanced breath-hold three-dimensional MR angiography of the portal vein: value of the magnetization-prepared rapid acquisition gradient-echo sequence.
Topics: Adult; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Hepatic Veins; Humans; Image Processing, Computer-Assisted; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Phantoms, Imaging; Portal Vein | 1996 |
Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Retrospective Studies | 1996 |
Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hepatic Artery; Humans; Injections; Liver; Liver Circulation; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Portal Vein | 1997 |
Hepatic lesion detection at MR imaging: a comparative study with four sequences.
Topics: Adipose Tissue; Adult; Aged; Area Under Curve; Contrast Media; Drug Combinations; Female; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Hepatectomy; Humans; Image Enhancement; Image Processing, Computer-Assisted; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Oxides; Pentetic Acid; Preoperative Care; ROC Curve; Sensitivity and Specificity; Single-Blind Method | 1997 |
Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Cysts; Drug Combinations; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Hemangioma, Cavernous; Hepatic Artery; Humans; Image Enhancement; Injections, Intra-Arterial; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Respiration; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method | 1997 |
Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement.
Topics: Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1997 |
Nontumorous hepatic pseudolesion around the falciform ligament: prevalence on gadolinium chelate-enhanced MR examination.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Ligaments; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies | 1997 |
Capsule of hepatocellular carcinoma: where and how does the capsule show enhancement?
Topics: Carcinoma, Hepatocellular; Contrast Media; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1999 |
[Effects of gadobenate dimeglumine on MRI of mouse liver metastasis model constructed by orthotopic transplantation of highly metastatic murine colon carcinoma (C38-OT7): comparison with gadopentetate dimeglumine].
Topics: Animals; Colonic Neoplasms; Contrast Media; Disease Models, Animal; Female; Gadolinium DTPA; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Organometallic Compounds | 1999 |
Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: results from phase II and phase III clinical trials in Japan.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Female; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Japan; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multicenter Studies as Topic; Organometallic Compounds | 1999 |
Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Time Factors | 2000 |
Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.
Topics: Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2000 |
Solitary hepatic infantile hemangioendothelioma: dynamic gadolinium-enhanced MR imaging findings.
Topics: Contrast Media; Female; Gadolinium; Hemangioendothelioma; Humans; Infant, Newborn; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2002 |
Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Topics: Acetates; Animals; Bile; Contrast Media; Duodenum; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Gallbladder; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Mice; Models, Statistical; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Time Factors | 1992 |
Visceral metastases from melanoma: findings on MR imaging.
Topics: Abdominal Neoplasms; Adult; Central Nervous System Neoplasms; Contrast Media; Drug Combinations; Eye Neoplasms; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Organometallic Compounds; Pentetic Acid; Soft Tissue Neoplasms | 1992 |